Bryan Tolliver to Affect
This is a "connection" page, showing publications Bryan Tolliver has written about Affect.
Connection Strength
0.387
-
A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Bipolar Disord. 2012 Feb; 14(1):54-63.
Score: 0.353
-
Identification and initial validation of empirically derived bipolar symptom states from a large longitudinal dataset: an application of hidden Markov modeling to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study. Psychol Med. 2019 05; 49(7):1102-1108.
Score: 0.035